Page last updated: 2024-10-26

econazole and Raynaud Disease

econazole has been researched along with Raynaud Disease in 1 studies

Econazole: An imidazole derivative that is commonly used as a topical antifungal agent.
econazole : A racemate composed of equimolar amounts of (R)- and (S)-econazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections.
1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 4-chlorobenzyl group.

Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Daftardar, S1
Bahl, D1
Boddu, SHS1
Altorok, N1
Kahaleh, B1

Other Studies

1 other study available for econazole and Raynaud Disease

ArticleYear
Ultrasound-mediated topical delivery of econazole nitrate with potential for treating Raynaud's phenomenon.
    International journal of pharmaceutics, 2020, Apr-30, Volume: 580

    Topics: Administration, Cutaneous; Animals; Antifungal Agents; Chemistry, Pharmaceutical; Econazole; Permeab

2020